Literature DB >> 12499261

Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

Jill A Fahrner1, Sayaka Eguchi, James G Herman, Stephen B Baylin.   

Abstract

We examined the relationship between aberrant DNA hypermethylation and key histone code components at a hypermethylated, silenced tumor suppressor gene promoter in human cancer. In lower eukaryotes, methylated H3-lysine 9 (methyl-H3-K9) determines DNA methylation and correlates with repressed gene transcription. Here we show that a zone of deacetylated histone H3 plus methyl-H3-K9 surrounds a hypermethylated, silenced hMLH1 promoter, which, when unmethylated and active, is embedded in methyl-H3-K4 and acetylated H3. Inhibiting DNA methyltransferases, but not histone deacetylases, leads first to promoter demethylation, second to gene reexpression, and finally to complete histone code reversal. Our findings suggest a new paradigm-DNA methylation may directly, or indirectly by inhibiting transcription, maintain key repressive elements of the histone code at a hypermethylated gene promoter in cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499261

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  103 in total

1.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

Authors:  Vesco Mutskov; Gary Felsenfeld
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

2.  Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation.

Authors:  Yutaka Kondo; Lanlan Shen; Pearlly S Yan; Tim Hui-Ming Huang; Jean-Pierre J Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

3.  Long-term stability of demethylation after transient exposure to 5-aza-2'-deoxycytidine correlates with sustained RNA polymerase II occupancy.

Authors:  Jacob D Kagey; Priya Kapoor-Vazirani; Michael T McCabe; Doris R Powell; Paula M Vertino
Journal:  Mol Cancer Res       Date:  2010-06-29       Impact factor: 5.852

Review 4.  Double-strand breaks and the concept of short- and long-term epigenetic memory.

Authors:  Christian Orlowski; Li-Jeen Mah; Raja S Vasireddy; Assam El-Osta; Tom C Karagiannis
Journal:  Chromosoma       Date:  2010-12-21       Impact factor: 4.316

5.  Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts.

Authors:  Vesselin M Chorbov; Alexandre A Todorov; Michael T Lynskey; Theodore J Cicero
Journal:  J Opioid Manag       Date:  2011 Jul-Aug

6.  Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Authors:  Biju Bhargavan; Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  Epigenetics       Date:  2013-02-05       Impact factor: 4.528

7.  Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.

Authors:  Joy C Lin; Shinwu Jeong; Gangning Liang; Daiya Takai; Merhnaz Fatemi; Yvonne C Tsai; Gerda Egger; Einav Nili Gal-Yam; Peter A Jones
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

8.  Chromosome segregation and organization are targets of 5'-Fluorouracil in eukaryotic cells.

Authors:  Laura Mojardín; Javier Botet; Sergio Moreno; Margarita Salas
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 9.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

10.  MDM2 regulates dihydrofolate reductase activity through monoubiquitination.

Authors:  Maria Maguire; Paul C Nield; Timothy Devling; Rosalind E Jenkins; B Kevin Park; Radoslaw Polański; Nikolina Vlatković; Mark T Boyd
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.